Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2014; 20(24): 7950-7954
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7950
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7950
Table 1 Clinical data of Fournier gangrene n (%)
Enterostomy group (n = 28) | Control group (n = 23) | P value | |
Gender (M/F) | 27/1 | 21/1 | > 0.05 |
Age (yr) | 49.3 ± 7.8 | 50.1 ± 8.9 | > 0.05 |
Disease course (from the onset to surgery) | 5.0 | 4.7 | > 0.05 |
FGSI score | 5.3 | 5.6 | > 0.05 |
Predisposing factors | |||
Diabetes | 22 (78.6) | 19 (82.6) | > 0.05 |
Cirrhosis | 19 (67.9) | 15 (54.3) | > 0.05 |
Renal failure | 3 (10.7) | 2 (8.7) | > 0.05 |
Initially infected regions | |||
Anal areas | 22 (89.3) | 11 (47.8) | > 0.05 |
Urogenital areas | 3 (10.7) | 9 (52.2) | > 0.05 |
Unknown | 3 (10.7) | 3 (13.0) | > 0.05 |
- Citation: Li YD, Zhu WF, Qiao JJ, Lin JJ. Enterostomy can decrease the mortality of patients with Fournier gangrene. World J Gastroenterol 2014; 20(24): 7950-7954
- URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7950